Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s):  CSCI

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone... see more

Bullboard (TSX:CSCI)

View:
Comment by prophetoffactzon Aug 27, 2024 8:43am

RE:The unexpected

The other industry tests may be worse than the industry expects and falsely classifying some subjects as growth hormone deficient? "Although further analysis of the study results is required ...more  
Comment by Schellajon Aug 27, 2024 8:42am

RE:The unexpected

And yet CSCI is down almost 50% on the American market this morning. 
Post by prophetoffactzon Aug 27, 2024 8:38am

The unexpected

1) Excellent safety was confirmed: "The top-line results confirm the excellent safety of macimorelin, similar to what was demonstrated in our clinical and commercial experience with the use of ...more  
Post by fossi_2002on Aug 27, 2024 8:00am

...did not meet primary endpoint

How much longer will the shareholders have to put up with this total miscast by the name of Gilles Gagnon and how much longer will we have to listen to the repetitive nonsense of Proph... .
Comment by prophetoffactzon Aug 27, 2024 12:54am

RE:RE:Perplexity Ai's expectations for pediatric trial results

Are these valid expectations? The pediatric trial compares macimorelin to clonidine and arginine. Here's what Perplexity Ai says including the other tests: Given this data, we can refine ...more  
Comment by prophetoffactzon Aug 26, 2024 11:21pm

RE:Perplexity Ai's expectations for pediatric trial results

After feeding Perplexity Ai more info about the dose finding pediatric trial this was its conclusion: This additional information provides valuable insights into the pediatric trial results for ...more  
Post by prophetoffactzon Aug 26, 2024 11:09pm

Perplexity Ai's expectations for pediatric trial results

I asked what sensitivity/specificity Perplexity Ai expected from the pediatric trial, how it compared to other tests, and gave it these previous pediatric results: "In all three dosing cohorts ...more  
Comment by prophetoffactzon Aug 26, 2024 2:39pm

RE:RE:RE:RE: Instant success

Hopeforthbest, why don't you show us any preclinical or clinical data for the avenanthramide pill? What is this fomulation they have created? Is it a slow-release formulation? How unique compared ...more  
Comment by Hopeforthebeston Aug 26, 2024 1:53pm

RE:RE:RE: Instant success

Everytime you post proph/gagnon, the banjo music is defeatening
Comment by prophetoffactzon Aug 26, 2024 1:42pm

RE:RE: Instant success

Hopeforthebest's lack of understanding of business is stunning. He has no idea what steath mode is as a company works towards key strategic milestones. As Hopeforthebest complains about ...more  
Post by Hopeforthebeston Aug 26, 2024 12:47pm

RE: Instant success

I always thought that proph's elevator did not go to top, you know, 2nd or 3rd cousin level, but this statement just blew that to brother sister parents level. It has to be about the dumbest ...more  
Post by prophetoffactzon Aug 26, 2024 10:42am

Instant success

Put yourself in Gilles shoes.The more information he puts in the public domain the greater the risk of being taken over for peanuts. Are we about to see 'instant' success, in a sense? From a ...more  
Post by prophetoffactzon Aug 25, 2024 8:46pm

Diagnostic

This is from 7 years ago but here talk on the diagnostic with an analyst and the company and timeline to approval, market size, etc. {^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities